Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.76 and traded as low as $3.33. ZIVO Bioscience shares last traded at $3.60, with a volume of 510 shares trading hands.
ZIVO Bioscience Stock Performance
The firm has a market cap of $17.28 million, a P/E ratio of -0.84 and a beta of 0.16. The stock has a fifty day simple moving average of $4.22 and a 200 day simple moving average of $4.76.
ZIVO Bioscience Company Profile
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Further Reading
- Five stocks we like better than ZIVO Bioscience
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
